Skip to content

New approaches to reduce mucosal candidal infections and voice prosthesis failure

Will drinking an anti-Candida milk product reduce damage to and improve time in situ for voice prostheses used by those who have undergone total laryngectomy

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000115336
Enrollment
8
Registered
2008-02-29
Start date
2008-04-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Voice prostheses (valves) made of silicone rubber are used to restore speech after laryngectomy for cancer of the larynx. These are frequently colonised by the common oral yeast Candida albicans, which damages and causes failure of teh prosthesis, nescessitating frequent replacement. The overall goal of our research is to develop new ways to prevent C albicans colonisation of voice prosthesis and subsequent valve failure. This proposal plans to evaluate the effect of ingesting bovine milk 9'immune milk') enriched with anti-C albicans IgA (antibody) on reducing voice prosthesis colonisation and damage. We shall perform a cross over study to compare the amount of valve colonisation and damage when an individual drinks either 'immune milk' or a control milk product without the anti-C albicans antibodies. Our hypotheseis is that valve damage will be reduced by treatment with an anti-Candida milk product, previously shown to reduce in vitro colonisation of oral surfaces by C albicans.

Interventions

The participants will drink a milk product which is reconstituted powedered bovine milk pooled from cows immunised with Candida albicans to create anti-candida albicans IgA. As a control the same milk product derived from non-immunised cows milk will be used. The milk product will be reconsituted with food grade water to a 2gm/L concentration. Twenty mls will be consumed twice daily for the period between valve changes. At entry to the study participants will undergo a voice prosthesis change an

The participants will drink a milk product which is reconstituted powedered bovine milk pooled from cows immunised with Candida albicans to create anti-candida albicans IgA. As a control the same milk product derived from non-immunised cows milk will be used. The milk product will be reconsituted with food grade water to a 2gm/L concentration. Twenty mls will be consumed twice daily for the period between valve changes. At entry to the study participants will undergo a voice prosthesis change and use one or other milk product for three months until the next voice prosthesis change. After the second change they will drink the other milk product for three months and then have a further voice prosthesis change. This is a crossover trial, the crossover point occurs at the time of a valve change, it is valve damage that is being assessed so washout should not be required

Sponsors

Mr Patrick Dawes
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

participant is using a silicone voice prosthesis as part of rehabilitation following total laryngectomy

Exclusion criteria

Allergy or intolerance to milk

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026